| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 12/19/2007 | EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 12/19/2007 | EP1465875B1 Novel alkansulfonamides as endothelin antagonists |
| 12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/19/2007 | EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 12/19/2007 | CN101090899A 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors |
| 12/19/2007 | CN100355728C Inhibitors of dipeptidyl peptidase IV |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309788 a selective N-alkylation reaction by adding a base; hydrolysing and amidating; useful for treating cardiovascular diseases caused by binding angiotensin II to its receptors, through antagonistic activity against angiotensin II receptors |
| 12/18/2007 | US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia |
| 12/18/2007 | US7309704 Piperidinyl- and pyrimidinyl-ureas: N-(1-acetyl-4-piperidinyl)-N-methyl-N'-(5-(3,5-difluorophenyl)-2-pyrimidinyl)urea; metabolic disorders, eating disorders, disorders associated with obesity: type II diabetes, insulin resistance, hyperlipidemia or hypertension. |
| 12/18/2007 | US7309701 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example |
| 12/18/2007 | CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 12/13/2007 | WO2007143724A2 Compositions and methods to enhance reverse cholesterol transport |
| 12/13/2007 | WO2007142929A2 Novel pde4 inhibitors |
| 12/13/2007 | WO2007142905A2 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 12/13/2007 | WO2007142584A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 12/13/2007 | WO2007141803A2 A process for the synthesis of (e) -2-[1 - (4 - methyl phenyl) -3-(1-pyrronyl)-1 - propenyl] pyridine (triprolidine) |
| 12/13/2007 | WO2007141039A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 12/13/2007 | WO2007127763A3 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 12/13/2007 | WO2007111904A3 C-met protein kinase inhibitors for the treatment of proliferative disorders |
| 12/13/2007 | WO2007109211A3 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 12/13/2007 | WO2007081560A3 Amino acid derivatives of indolinone based protein kinase inhibitors |
| 12/13/2007 | WO2007070506A3 Diaza heterocyclic sulfonamide derivatives and their uses |
| 12/13/2007 | WO2007061763A3 Indole orexin receptor antagonists |
| 12/13/2007 | US20070287734 Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity |
| 12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 12/13/2007 | US20070287708 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 12/13/2007 | US20070287700 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 12/13/2007 | US20070287695 Novel Compounds |
| 12/13/2007 | US20070287693 Benzamide Derivatives That Act Upon The Glucokinase Enzyme |
| 12/13/2007 | US20070287692 Aspartyl protease inhibitors |
| 12/13/2007 | CA2653526A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 12/13/2007 | CA2650082A1 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
| 12/12/2007 | EP1864976A1 Propane-1,3-dion derivative or salt thereof |
| 12/12/2007 | EP1864665A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 12/12/2007 | EP1863871A1 Rubber composition comprising an itaconimido-maleimide |
| 12/12/2007 | EP1863805A1 Pyrimidine compounds having tie2 (tek) inhibitory activity |
| 12/12/2007 | EP1863797A1 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY |
| 12/12/2007 | EP1863796A1 Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use |
| 12/12/2007 | EP1863794A2 Pyrimidine compounds and methods of use |
| 12/12/2007 | EP1863793A2 Hepatitis c virus inhibitors |
| 12/12/2007 | EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 12/12/2007 | EP1863765A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents |
| 12/12/2007 | EP1863484A1 Substituted triazole derivatives as oxytocin antagonists |
| 12/12/2007 | EP1863477A1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 12/12/2007 | EP1725526B1 Method for preparing pyrrolidine oximes |
| 12/12/2007 | EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/12/2007 | EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 12/12/2007 | EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
| 12/12/2007 | CN101087784A Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| 12/12/2007 | CN101087781A Indole derivatives for treating pulmonary tuberculosis |
| 12/12/2007 | CN101087778A Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors |
| 12/12/2007 | CN101087777A Pyrrolidinium derivatives as M3 muscarinic receptors |
| 12/12/2007 | CN101087776A Organic compound, charge-transporting material, and organic electroluminescent element |
| 12/12/2007 | CN101087766A Pyridazine compounds, compositions and methods |
| 12/12/2007 | CN101087765A Fused pyrazole derivatives and uses of methods of treatment of metabolic-related disorders thereof |
| 12/12/2007 | CN101087764A Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 12/12/2007 | CN101087609A Factor Xa compounds |
| 12/12/2007 | CN101087606A 雌激素受体调节剂 Estrogen receptor modulators |
| 12/12/2007 | CN101085773A Polyamide bisbenzimidazole compound, preparation method and application thereof |
| 12/12/2007 | CN101085772A Compound with PPARgamma excitant activity and application thereof |
| 12/12/2007 | CN101085771A Method for preparing rizatriptan benzoate |
| 12/12/2007 | CN100354271C Piperazine derivatives and process for the preparation thereof |
| 12/11/2007 | US7307170 Epindolidione pigments |
| 12/11/2007 | US7307169 Isotopically enriched N-substituted piperazines and methods for the preparation thereof |
| 12/11/2007 | US7307097 Chemical compounds |
| 12/11/2007 | US7307095 Osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis, (S)-2-(Benzooxazol-2-ylamino)-3-cyclohexyl-N-[2-(5-fluoro-2,3-dihydro-indol-1-yl)-ethyl]-propionamide |
| 12/11/2007 | US7307088 Substituted anthranilic amide derivatives and methods of use |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | US7307086 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
| 12/11/2007 | US7307079 Treating acute and chronic pain and inflammatory, gastrointestinal, allergic, cardiovascular, skin, opthalmological, respiratory, nervous system, cognition and memory disorders, etc. |
| 12/11/2007 | US7307077 Heterocyclic compound and antitumor agent containing the same as effective ingredient |
| 12/11/2007 | US7307074 Diazepan derivatives or salts thereof |
| 12/06/2007 | WO2007140183A1 Fxr agonists |
| 12/06/2007 | WO2007140174A2 Compounds and methods for modulating fxr |
| 12/06/2007 | WO2007139968A2 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | WO2007139955A2 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138468A2 Processes for the preparation of lansoprazole |
| 12/06/2007 | WO2007138277A1 2-carbocycloamino-4-imidaz0lylpyrimidines as agents for the inhbition of cell proliferation |
| 12/06/2007 | WO2007138268A1 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation |
| 12/06/2007 | WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
| 12/06/2007 | WO2007137955A1 Piperidinyl pyrimidine derivatives |
| 12/06/2007 | WO2007137953A1 Benzazepine derivatives as monoamine reuptake inhibitors |
| 12/06/2007 | WO2007137417A1 Heterocyclic compounds as calcium channel blockers |
| 12/06/2007 | WO2007105053A3 Tetralines antagonists of the h-3 receptor |
| 12/06/2007 | WO2007076360A8 (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions |
| 12/06/2007 | WO2007068894A3 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
| 12/06/2007 | WO2006067428A3 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 12/06/2007 | US20070281973 such as 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylsulfanyl-N-(pyrrolidin-1-yl)-1H-pyrazole-3-carboxamide, used for the treatment of psychological and nervous system disorders |
| 12/06/2007 | US20070281956 Phenylpyrimidine amines as IgE inhibitors |
| 12/06/2007 | US20070281949 such as 3-(2-Cyclopentyl-2H-pyrazolo[3,4-d]pyrimidin-4-yl)-2-oxo-2,3-dihydro-1H-indole-5-carbonitrile, use in the treatment of neurodegenerative diseases, neurotraumatic diseases, depression and/or diabetes |
| 12/06/2007 | US20070281932 Method of preparing 4-halogenated quinoline intermediates |
| 12/06/2007 | US20070281923 (4-Cyclopropyl-[1,4]diazepan-1-yl)-[6-(3,4-dichloro-phenoxy)-pyridin-3-yl]-methanone; (4-cyclobutyl-[1,4]diazepan-1-yl)-[6-(4-fluoro-phenoxy)-pyridin-3-yl]-methanone hydrochloride monohydrate; cognitive disorders, sleep disorders, psychiatric disorders |
| 12/06/2007 | US20070281922 1-Sulfonylindazolylamine and - amide derivatives as 5-hydroxytryptamine-6 ligands |
| 12/06/2007 | US20070281921 Piperidinyl pyrimidine derivatives |
| 12/06/2007 | US20070281920 5-(1H-indol-5-yl)-2-methyl-2,3,4,5-tetrahydro-1H-benzo[c]azepine; for treatment of monoamine reuptake inhibitor-mediated diseases such as depression, anxiety, genitourinary disorders and pain |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |